Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting

NCT04352140
completednot_applicable

Comparison of the TOFScan and the WiTOF During Recovery of Neuromuscular Function

NCT05231525
completed

Comparison of TOFscan and TOF-Watch SX in Pediatric Neuromuscular Function Recovery

NCT03775603
unknownphase_4

Acceleromyographic Assessment of Neuromuscular Blockade: TOF-Watch-SX Versus TOFscan

NCT02433769

Clinical Trials (4)

Showing 4 of 4 trials
NCT04352140Not Applicable

Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting

Completed
NCT05231525Not Applicable

Comparison of the TOFScan and the WiTOF During Recovery of Neuromuscular Function

Completed
NCT03775603

Comparison of TOFscan and TOF-Watch SX in Pediatric Neuromuscular Function Recovery

Completed
NCT02433769Phase 4

Acceleromyographic Assessment of Neuromuscular Blockade: TOF-Watch-SX Versus TOFscan

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4